相关实验视频
Updated: Jul 6, 2025

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.5K
卡普托普里尔挑战测试:在诊断原发性阿尔多斯特主义时未被充分利用的测试
Sharmin Jahan1,2,3, Jun Yang1,2, Jinbo Hu4
1Department of Medicine, Monash University, Melbourne, Victoria, Australia.
Endocrine connections
|January 5, 2024
概括
主要阿尔多斯特主义 (PA) 诊断可以使用卡普托普里尔挑战测试 (CCT) 来改善. 本综述探讨了CCT的使用情况.
科学领域:
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
- 高血压研究 高血压研究
背景情况:
- 原发性阿尔多斯特隆症 (PA) 是内分泌高血压的常见,未被确诊的原因.
- 与基本高血压 (EH) 相比,PA增加了心血管风险.
- 目前的PA诊断包括查,确认和亚型,确认测试缺乏普遍标准化.
研究的目的:
- 为了评估卡普托普里尔挑战测试 (CCT) 对原发性阿尔多斯泰隆症的诊断准确性.
- 解决争议,并为使用CCT提出建议.
- 建议未来的研究,以便更广泛地采用CCT.
主要方法:
- 卡普托普里尔挑战测试 (CCT) 诊断准确性的叙述性审查.
- 在不同患者群体中评估CCT.
- 分析CCT协议和诊断值的可变性.
主要成果:
- 卡波普里尔挑战测试 (CCT) 是一种安全,廉价和方便的PA诊断替代方案,可在其他测试适用时使用.
- 尽管有优势,但CCT协议 (剂量,姿势,值) 的变化限制了其广泛采用.
- 该审查评估了CCT的诊断准确性,并确定了需要标准化的领域.
结论:
- 卡普托普里尔挑战测试 (CCT) 提出了一个有希望的,更安全和更具成本效益的选择,用于初级阿尔多斯特症的诊断.
- 标准化CCT协议对于提高其诊断准确性和临床实用性至关重要.
- 建议进行进一步的研究,以促进在PA诊断中更广泛地使用CCT.
相关概念视频
Antihypertensive Drugs: Potassium-Sparing Diuretics
569
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
569
Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
645
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
645
Adrenal Gland Disorders
1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
Hormonal Regulation
33.2K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.2K

